Literature DB >> 30149283

Affect and cannabis use in daily life: a review and recommendations for future research.

Andrea M Wycoff1, Jane Metrik2, Timothy J Trull3.   

Abstract

BACKGROUND: Although cannabis is often used for the purposes of relieving negative affective states such as anxiety and depression, the associations between cannabis use and affect in daily life are unclear. Ecological momentary assessment (EMA) has been used to study these associations in individuals' natural environments, providing more ecological validity, minimizing retrospective bias, and allowing for the analysis of within-individual processes over time. This review focuses on studies that utilized EMA to examine daily-life associations of cannabis use and negative and positive affective states.
METHODS: We review the findings of the 19 articles that met inclusion criteria, including clinical and community samples.
RESULTS: Results provide equivocal evidence regarding relations between cannabis use and affect for community samples. Findings are mixed for clinical samples as well, but more consistent patterns emerge for general negative affect (NA) and anger/hostility at the momentary level; cannabis use may be more likely following increased NA and lead to decreases in NA and anger/hostility in psychiatric populations.
CONCLUSIONS: Findings support a negative reinforcement hypothesis for clinical samples in terms of general NA and anger/hostility. However, discrepancies among studies point to a need to thoroughly characterize samples, consider motives for and expectancies of use, improve quantification of cannabis use, and consider co-use with other substances. Additional design recommendations are also offered for future studies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabis; Ecological momentary assessment; Marijuana; Negative affect; Positive affect

Mesh:

Year:  2018        PMID: 30149283      PMCID: PMC6201696          DOI: 10.1016/j.drugalcdep.2018.07.001

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  65 in total

1.  Immediate antecedents of marijuana use: an analysis from ecological momentary assessment.

Authors:  Julia D Buckner; Ross D Crosby; Jose Silgado; Stephen A Wonderlich; Norman B Schmidt
Journal:  J Behav Ther Exp Psychiatry       Date:  2011-09-14

Review 2.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

3.  Momentary positive and negative affect preceding marijuana use events in youth.

Authors:  Lydia A Shrier; Craig S Ross; Emily A Blood
Journal:  J Stud Alcohol Drugs       Date:  2014-09       Impact factor: 2.582

4.  Effects of acute smoked marijuana on complex cognitive performance.

Authors:  C L Hart; W van Gorp; M Haney; R W Foltin; M W Fischman
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

5.  Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Kevin P Conway; Wilson Compton; Frederick S Stinson; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

Review 6.  Cannabis effects on driving skills.

Authors:  Rebecca L Hartman; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-12-07       Impact factor: 8.327

7.  Marijuana use and the risk of Major Depressive Episode. Epidemiological evidence from the United States National Comorbidity Survey.

Authors:  Chuan-Yu Chen; Fernando A Wagner; James C Anthony
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2002-05       Impact factor: 4.328

8.  The time course and significance of cannabis withdrawal.

Authors:  Alan J Budney; Brent A Moore; Ryan G Vandrey; John R Hughes
Journal:  J Abnorm Psychol       Date:  2003-08

9.  Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.

Authors:  Paolo Fusar-Poli; José A Crippa; Sagnik Bhattacharyya; Stefan J Borgwardt; Paul Allen; Rocio Martin-Santos; Marc Seal; Simon A Surguladze; Colin O'Carrol; Zerrin Atakan; Antonio W Zuardi; Philip K McGuire
Journal:  Arch Gen Psychiatry       Date:  2009-01

10.  Cannabis Use and Risk of Psychiatric Disorders: Prospective Evidence From a US National Longitudinal Study.

Authors:  Carlos Blanco; Deborah S Hasin; Melanie M Wall; Ludwing Flórez-Salamanca; Nicolas Hoertel; Shuai Wang; Bradley T Kerridge; Mark Olfson
Journal:  JAMA Psychiatry       Date:  2016-04       Impact factor: 21.596

View more
  18 in total

Review 1.  The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

Authors:  Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

2.  A comparison of signal- and event-contingent ambulatory assessment of interpersonal behavior and affect in social situations.

Authors:  Philip H Himmelstein; William C Woods; Aidan G C Wright
Journal:  Psychol Assess       Date:  2019-04-08

3.  Comorbidity and Coaggregation of Major Depressive Disorder and Bipolar Disorder and Cannabis Use Disorder in a Controlled Family Study.

Authors:  Courtney R Quick; Kevin P Conway; Joel Swendsen; Emma K Stapp; Lihong Cui; Kathleen R Merikangas
Journal:  JAMA Psychiatry       Date:  2022-07-01       Impact factor: 25.911

4.  Momentary patterns of alcohol and cannabis co-use in college students: Assessing the temporal association with anxiety.

Authors:  Kristina T Phillips; Mark A Prince; Michael M Phillips; Trent L Lalonde; Michael D Stein
Journal:  Cannabis       Date:  2021-12-17

5.  Pharmacotherapy for the Treatment of Cannabis Use Disorder.

Authors:  Christina A Brezing; Frances R Levin
Journal:  Ann Intern Med       Date:  2020-08-04       Impact factor: 25.391

6.  Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.

Authors:  Rachel L Tomko; Nathaniel L Baker; Caitlyn O Hood; Amanda K Gilmore; Erin A McClure; Lindsay M Squeglia; Aimee L McRae-Clark; Susan C Sonne; Kevin M Gray
Journal:  Psychopharmacology (Berl)       Date:  2019-11-11       Impact factor: 4.530

Review 7.  Down and High: Reflections Regarding Depression and Cannabis.

Authors:  Catherine Langlois; Stéphane Potvin; Atul Khullar; Smadar Valérie Tourjman
Journal:  Front Psychiatry       Date:  2021-05-14       Impact factor: 4.157

8.  A qualitative examination of intentions and willingness for heavy drinking among young adult high-intensity drinkers.

Authors:  Angela K Stevens; Holly K Boyle; Mary B Miller; Kate Carey; Kristina M Jackson; Nancy P Barnett; Jennifer E Merrill
Journal:  Psychol Addict Behav       Date:  2021-03-18

9.  From Enchantment to Disillusion: A Narrative Exploration of Cannabis Use Disorder Among Young Israeli Combat Veterans.

Authors:  Miri Serebro; Shira Sobol-Goldberg; Daniel Feingold
Journal:  Front Psychiatry       Date:  2021-06-18       Impact factor: 4.157

10.  Adverse effects of heavy cannabis use: even plants can harm the brain.

Authors:  Lucia Sideli; Giulia Trotta; Edoardo Spinazzola; Caterina La Cascia; Marta Di Forti
Journal:  Pain       Date:  2021-07-01       Impact factor: 6.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.